Literature DB >> 27027299

Surgical treatment for diabetic vitreoretinal diseases: a review.

Tarun Sharma1, Angie Fong2, Timothy Y Lai3, Vincent Lee4, Sudipta Das5, Dennis Lam4,5.   

Abstract

Over the past four decades, advancements in surgical instrumentations and techniques have significantly improved the postoperative anatomical and visual outcomes of patients with various diabetic vitreoretinal diseases. In particular, surgical interventions for previously serious and untreatable blinding proliferative diabetic retinopathy can now be performed, with much better results. The advents of micro incisional vitrectomy system with better visualization system like binocular indirect ophthalmomicroscope and state-of-the-art instrumentation revolutionized the era of diabetic vitrectomy. High-speed vitrectors, finer instruments, chromo-assisted vitrectomy and use of anti-vascular endothelial growth factors not only change the paradigm but also help achieve much better outcome after diabetic vitrectomies. In this review, we will discuss and summarize the indications, surgical considerations, surgical techniques, potential complications and outcomes of vitreoretinal surgery for diabetic eye diseases.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  diabetic macular edema; diabetic retinopathy; proliferative diabetic retinopathy; retinal detachment; vitreoretinal surgery

Mesh:

Year:  2016        PMID: 27027299     DOI: 10.1111/ceo.12752

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  12 in total

1.  Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.

Authors:  Gang Qiao; Wan-Jiang Dong; Yan Dai; Zhen-Hua Jiang; Hai-Ke Guo
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

Review 2.  Update on Diagnosis and Treatment of Diabetic Retinopathy: A Consensus Guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society).

Authors:  Borja Corcóstegui; Santiago Durán; María Olga González-Albarrán; Cristina Hernández; José María Ruiz-Moreno; Javier Salvador; Patricia Udaondo; Rafael Simó
Journal:  J Ophthalmol       Date:  2017-06-14       Impact factor: 1.909

3.  Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).

Authors:  Xu Liang; Yue Zhang; Jia-Xing Wang; Li-Fei Wang; Wan-Rong Huang; Xin Tang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy.

Authors:  Hasenin Al-Khersan; Michael J Venincasa; Amy Kloosterboer; Jayanth Sridhar; William E Smiddy; Justin H Townsend; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2020-06-10

Review 5.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04

6.  Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy.

Authors:  Katsuhiro Nishi; Koichi Nishitsuka; Teiko Yamamoto; Hidetoshi Yamashita
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

Review 7.  Current and novel multi-imaging modalities to assess retinal oxygenation and blood flow.

Authors:  Michael J Marino; Peter L Gehlbach; Abhishek Rege; Kim Jiramongkolchai
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

8.  Repair of primary RRD - comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantation.

Authors:  Sirpa Loukovaara; Jari Haukka
Journal:  Clin Ophthalmol       Date:  2018-08-15

Review 9.  The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy.

Authors:  Meng-Yu Wu; Giou-Teng Yiang; Tzu-Ting Lai; Chia-Jung Li
Journal:  Oxid Med Cell Longev       Date:  2018-09-05       Impact factor: 6.543

10.  Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation.

Authors:  R Ganugula; M Arora; M A Lepiz; Y Niu; B K Mallick; S C Pflugfelder; E M Scott; M N V Ravi Kumar
Journal:  Sci Adv       Date:  2020-08-26       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.